Sensor Measures Oxygen Levels Within Specific Human Tissue, Potentially Allowing Biosensor Feedback of Erectile Device…
Novozymes delivered solid earnings and double-digit organic sales growth in the first quarter of 2022….
Please read the full announcement in PDF Attachment 2022_14_Q12022_CompanyAnnouncement
DURHAM, N.C., April 26, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
Low-code application development tool helps organizations rapidly build and deploy business applications up to 10x…
DENVER, April 26, 2022 (GLOBE NEWSWIRE) — Cannabis retail sales on 4/20 continued to increase…
CHICAGO, April 26, 2022 (GLOBE NEWSWIRE) — VelocityEHS, the global leader in cloud-based environmental, health, safety…
Singapore, Singapore–(Newsfile Corp. – April 26, 2022) – Oobit Technologies Pte. Ltd or “the Company”, a…
Placentia, California–(Newsfile Corp. – April 26, 2022) – InVitro International (OTC PINK: IVRO), an established…
NEW YORK, NY, Apr 26, 2022 – (ACN Newswire) – The crowdsourcing DAO Vetter.ai is…
New platform utilizes data and artificial intelligence to better and more accurately match investors and…
News highlights Solidigm is adding two new product lines, the D7-P5520 and the D7-P5620, to…
Two new projectors provide cinema operators, art houses, and museums with unparalleled image quality while…
An Extension of Alorica Anywhere, This New Workforce Optimization Model Provides Additional Flexibility and Enhanced…
CHICAGO–(BUSINESS WIRE)–May River Capital, a Chicago-based private equity firm focused on lower middle market industrial…
DUBLIN–(BUSINESS WIRE)–The “Global Artificial Intelligence of Things (AIoT) in Telecommunications Growth Opportunities” report has been…
Offers fast-track automation across 20+ channels in voice and chat with 360-degree Customer Engagement SAN…
Adept is building a natural language interface to everyday software tools SAN FRANCISCO–(BUSINESS WIRE)–Adept, a…
AUSTIN, Tex., April 26, 2022 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical…
CAMBRIDGE, Mass., April 26, 2022 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing…